David D. O'Toole, Chief Financial Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 3,000 shares at $18.85 ($57K) on 2018-05-11, disclosed to the SEC on 2018-05-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |